1-20 of 23
fibrosis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold

Laurent Castera, Cédric Laouenan, Anaïs Vallet-Pichard, Tiphaine Vidal-Trécan, Pauline Manchon, Valérie Paradis, Dominique Roulot, Nathalie Gault, Christian Boitard, Benoit Terris, Hélène Bihan, Jean-Baptiste Julla, Alina Radu, Thierry Poynard, Angélique Brzustowsky, Etienne Larger, Sébastien Czernichow, Stanislas Pol, Pierre Bedossa, Dominique Valla, Jean-François Gautier, QUID NASH investigators , Christophe Junot, Bernard Van Beers, Christian Boitard, Nathalie de Préville, Isabelle Durand Zaleski, Pierre-Emmanuel Rautou, Marco Dioguardi, Valérie Vilgrain, Jean-Pierre Riveline
Journal: Diabetes Care
Diabetes Care dc222048
DOI: https://doi.org/10.2337/dc22-2048
Published: 12 April 2023
View article titled, High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold
Click here to open pdf in another window PDF for High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold
Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023

Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Kenneth Cusi, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Journal: Diabetes Care
Diabetes Care 2023;46(Supplement_1):S49–S67
DOI: https://doi.org/10.2337/dc23-S004
Published: 12 December 2022
View article titled, 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023
Click here to open pdf in another window PDF for 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023
Journal Articles

Myocardial Extracellular Volume Expansion in Type 2 Diabetes Is Associated With Ischemic Heart Disease, Autonomic Neuropathy, and Active Smoking

Annemie Stege Bojer, Martin Heyn Sørensen, Peter Gæde, Per Lav Madsen
Journal: Diabetes Care
Diabetes Care 2022;45(12):3032–3039
DOI: https://doi.org/10.2337/dc22-0942
Published: 10 October 2022
View article titled, Myocardial Extracellular Volume Expansion in Type 2 Diabetes Is Associated With Ischemic Heart Disease, Autonomic Neuropathy, and Active Smoking
Click here to open pdf in another window PDF for Myocardial Extracellular Volume Expansion in Type 2 Diabetes Is Associated With Ischemic Heart Disease, Autonomic Neuropathy, and Active Smoking
Journal Articles

Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score Accuracy

Rebecca G. Kim, Jasmine Deng, Jewel N. Reaso, James P. Grenert, Mandana Khalili
Journal: Diabetes Care
Diabetes Care 2022;45(10):2449–2451
DOI: https://doi.org/10.2337/dc22-0556
Published: 10 August 2022
View article titled, Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score Accuracy
Click here to open pdf in another window PDF for Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score Accuracy
Journal Articles

Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial

Yumie Takeshita, Masao Honda, Kenichi Harada, Yuki Kita, Noboru Takata, Hiromasa Tsujiguchi, Takeo Tanaka, Hisanori Goto, Yujiro Nakano, Noriho Iida, Kuniaki Arai, Tatsuya Yamashita, Eishiro Mizukoshi, Hiroyuki Nakamura, Shuichi Kaneko, Toshinari Takamura
Journal: Diabetes Care
Diabetes Care 2022;45(9):2064–2075
DOI: https://doi.org/10.2337/dc21-2049
Published: 27 July 2022
View article titled, Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial
Click here to open pdf in another window PDF for Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial
Journal Articles

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional Practice Committee
Journal: Diabetes Care
Diabetes Care 2022;45(Supplement_1):S46–S59
DOI: https://doi.org/10.2337/dc22-S004
Published: 16 December 2021
View article titled, 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022
Click here to open pdf in another window PDF for 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022
Journal Articles

Preparing for the NASH Epidemic: A Call to Action

Fasiha Kanwal, Jay H. Shubrook, Zobair Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E. Rinella, Stephen A. Harrison, Christos Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H. Eckel, Davida Kruger, Hashem El-Serag, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2021;44(9):2162–2172
DOI: https://doi.org/10.2337/dci21-0020
Published: 26 July 2021
View article titled, Preparing for the NASH Epidemic: A Call to Action
Click here to open pdf in another window PDF for Preparing for the NASH Epidemic: A Call to Action
Journal Articles

Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes

Chi-Ho Lee, Wai-Kay Seto, David Tak-Wai Lui, Carol Ho-Yi Fong, Helen Yilin Wan, Chloe Yu-Yan Cheung, Wing-Sun Chow, Yu-Cho Woo, Man-Fung Yuen, Aimin Xu, Karen Siu-Ling Lam
Journal: Diabetes Care
Diabetes Care 2021;44(9):2089–2097
DOI: https://doi.org/10.2337/dc21-0131
Published: 28 June 2021
View article titled, Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes
Click here to open pdf in another window PDF for Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes
Journal Articles

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

Romina Lomonaco, Eddison Godinez Leiva, Fernando Bril, Sulav Shrestha, Lydia Mansour, Jeff Budd, Jessica Portillo Romero, Siegfried Schmidt, Ku-Lang Chang, George Samraj, John Malaty, Katherine Huber, Pierre Bedossa, Srilaxmi Kalavalapalli, Jonathan Marte, Diana Barb, Danielle Poulton, Nada Fanous, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2021;44(2):399–406
DOI: https://doi.org/10.2337/dc20-1997
Published: 13 January 2021
View article titled, Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
Click here to open pdf in another window PDF for Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
Journal Articles

Presence of Liver Steatosis Is Associated With Greater Diabetes Remission After Gastric Bypass Surgery

Roman Vangoitsenhoven, Rickesha L. Wilson, Deepa V. Cherla, Chao Tu, Sangeeta R. Kashyap, David E. Cummings, Philip R. Schauer, Ali Aminian
Journal: Diabetes Care
Diabetes Care 2021;44(2):321–325
DOI: https://doi.org/10.2337/dc20-0150
Published: 15 December 2020
View article titled, Presence of Liver Steatosis Is Associated With Greater Diabetes Remission After Gastric Bypass Surgery
Click here to open pdf in another window PDF for Presence of Liver Steatosis Is Associated With Greater Diabetes Remission After Gastric Bypass Surgery
Journal Articles

High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes

Stefano Ciardullo, Tommaso Monti, Gianluca Perseghin
Journal: Diabetes Care
Diabetes Care 2021;44(2):519–525
DOI: https://doi.org/10.2337/dc20-1778
Published: 10 December 2020
View article titled, High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
Click here to open pdf in another window PDF for High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
Journal Articles

Role of Patatin-Like Phospholipase Domain–Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes

Oana P. Zaharia, Klaus Strassburger, Birgit Knebel, Yuliya Kupriyanova, Yanislava Karusheva, Martin Wolkersdorfer, Kálmán Bódis, Daniel F. Markgraf, Volker Burkart, Jong-Hee Hwang, Jörg Kotzka, Hadi Al-Hasani, Julia Szendroedi, Michael Roden, GDS Group, M. Roden, H. Al-Hasani, V. Burkart, A.E. Buyken, J. Eckel, G. Geerling, J.H. Hwang, C. Herder, A. Icks, K. Jandeleit-Dahm, S. Kahl, J. Kotzka, O. Kuss, E. Lammert, S. Trenkamp, W. Rathmann, J. Szendroedi, D. Ziegler
Journal: Diabetes Care
Diabetes Care 2020;43(9):2161–2168
DOI: https://doi.org/10.2337/dc20-0329
Published: 19 June 2020
View article titled, Role of Patatin-Like Phospholipase Domain–Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes
Click here to open pdf in another window PDF for Role of Patatin-Like Phospholipase Domain–Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes
Journal Articles

Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes

Fernando Bril, Michael J. McPhaul, Michael P. Caulfield, Virginia C. Clark, Consuelo Soldevilla-Pico, Roberto J. Firpi-Morell, Jinping Lai, Dov Shiffman, Charles M. Rowland, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2020;43(2):290–297
DOI: https://doi.org/10.2337/dc19-1071
Published: 11 October 2019
View article titled, Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
Click here to open pdf in another window PDF for Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
Includes: Supplementary data
Journal Articles

Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes

Alexandre Jehl, Christine Cugnet-Anceau, Corinne Vigouroux, Anne L. Legeay, Stéphane Dalle, Olivier Harou, Lucien Marchand, Olivier Lascols, Cyrielle Caussy, Charles Thivolet, Martine Laville, Emmanuel Disse
Journal: Diabetes Care
Diabetes Care 2019;42(10):2008–2010
DOI: https://doi.org/10.2337/dc18-2535
Published: 21 August 2019
View article titled, Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes
Click here to open pdf in another window PDF for Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes
Includes: Supplementary data
Journal Articles

Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial

Fernando Bril, Diane M. Biernacki, Srilaxmi Kalavalapalli, Romina Lomonaco, Sreevidya K. Subbarayan, Jinping Lai, Fermin Tio, Amitabh Suman, Beverly K. Orsak, Joan Hecht, Kenneth Cusi
Journal: Diabetes Care
Diabetes Care 2019;42(8):1481–1488
DOI: https://doi.org/10.2337/dc19-0167
Published: 21 May 2019
View article titled, Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Click here to open pdf in another window PDF for Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Includes: Supplementary data
Journal Articles

Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes

Ahmed Al-Badri, Zeba Hashmath, Garrett H. Oldland, Rachana Miller, Khuzaima Javaid, Amer Ahmed Syed, Bilal Ansari, Swetha Gaddam, Walter R. Witschey, Scott R. Akers, Julio A. Chirinos
Journal: Diabetes Care
Diabetes Care 2018;41(9):2019–2025
DOI: https://doi.org/10.2337/dc18-0324
Published: 12 July 2018
View article titled, Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes
Click here to open pdf in another window PDF for Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes
Journal Articles

Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria

Daniel G.K. Rasmussen, Tine W. Hansen, Bernt J. von Scholten, Signe H. Nielsen, Henrik Reinhard, Hans-Henrik Parving, Martin Tepel, Morten A. Karsdal, Peter K. Jacobsen, Federica Genovese, Peter Rossing
Journal: Diabetes Care
Diabetes Care 2018;41(7):1493–1500
DOI: https://doi.org/10.2337/dc17-2392
Published: 11 April 2018
View article titled, Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria
Click here to open pdf in another window PDF for Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria
Includes: Supplementary data
Journal Articles

Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B

Mandana Khalili, Margaret C. Shuhart, Manuel Lombardero, Jordan J. Feld, David E. Kleiner, Raymond T. Chung, Norah A. Terrault, Mauricio Lisker-Melman, Arun Sanyal, Anna S. Lok, for the Hepatitis B Research Network (HBRN)
Journal: Diabetes Care
Diabetes Care 2018;41(6):1251–1259
DOI: https://doi.org/10.2337/dc18-0040
Published: 29 March 2018
View article titled, Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B
Click here to open pdf in another window PDF for Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B
Includes: Supplementary data
Journal Articles

Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial

Daisuke Ito, Satoshi Shimizu, Kazuyuki Inoue, Daigo Saito, Morifumi Yanagisawa, Kouichi Inukai, Yuji Akiyama, Yoshihiro Morimoto, Mitsuhiko Noda, Akira Shimada
Journal: Diabetes Care
Diabetes Care 2017;40(10):1364–1372
DOI: https://doi.org/10.2337/dc17-0518
Published: 27 July 2017
View article titled, Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial
Click here to open pdf in another window PDF for Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial
Includes: Supplementary data
Journal Articles

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD

Jessica Bazick, Michele Donithan, Brent A. Neuschwander-Tetri, David Kleiner, Elizabeth M. Brunt, Laura Wilson, Ed Doo, Joel Lavine, James Tonascia, Rohit Loomba
Journal: Diabetes Care
Diabetes Care 2015;38(7):1347–1355
DOI: https://doi.org/10.2337/dc14-1239
Published: 17 April 2015
View article titled, Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
Click here to open pdf in another window PDF for Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
Includes: Supplementary data